Preclinical Imaging Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Preclinical Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Social landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Preclinical Imaging Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Preclinical Imaging Type Market Movement Analysis
• 4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Modality
  • 4.4.1. Modality market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Optical Imaging (BLI & F)
    • 4.4.2.1. Optical Imaging (BLI & F) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. Magnetic Resonance Imaging (MRI)
    • 4.4.3.1. Magnetic Resonance Imaging (MRI) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.4. Positron Emission Tomography (PET)
    • 4.4.4.1. Positron Emission Tomography (PET) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.5. Single Photon Emission Computed Tomography (SPECT)
    • 4.4.5.1. Single Photon Emission Computed Tomography (SPECT) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.6. Computed Tomography (CT)
    • 4.4.6.1. Computed Tomography (CT) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.7. Ultrasound Imaging (US)
    • 4.4.7.1. Ultrasound Imaging (US) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.8. Photoacoustic Imaging (PAI)
    • 4.4.8.1. Photoacoustic Imaging (PAI) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.9. Hybrid Imaging Systems
    • 4.4.9.1. Hybrid Imaging Systems market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.9.2. Bi-Modal
      • 4.4.9.2.1. Bi-Modal market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2.2. SPECT-CT
        • 4.4.9.2.2.1. SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2.3. PET-CT
        • 4.4.9.2.3.1. PET-CT market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2.4. SPECT-PET
        • 4.4.9.2.4.1. SPECT-PET market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2.5. PET-MRI
        • 4.4.9.2.5.1. PET-MRI market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2.6. Optical-CT
        • 4.4.9.2.6.1. Optical-CT market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2.7. Others
        • 4.4.9.2.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.9.3. Tri-Modal
      • 4.4.9.3.1. Tri-Modal market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.3.2. PET-SPECT-CT
        • 4.4.9.3.2.1. PET-SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.3.3. PET-SPECT-MRI
        • 4.4.9.3.3.1. PET-SPECT-MRI market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.3.4. PET-CT-Optical
        • 4.4.9.3.4.1. PET-CT-Optical market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.3.5. Others
        • 4.4.9.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.10. Others
    • 4.4.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Reagent
  • 4.5.1. Reagent market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Service
  • 4.6.1. Service market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Preclinical Imaging Application Market Movement Analysis
• 5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Drug Discovery & Development
  • 5.4.1. Drug Discovery & Development market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Toxicology & Pharmacokinetics Studies
  • 5.5.1. Toxicology & Pharmacokinetics Studies market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Basic & Translational Research
  • 5.6.1. Basic & Translational Research market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. Disease Mechanism & Pathophysiology Studies
  • 5.7.1. Disease Mechanism & Pathophysiology Studies market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.2. Oncology
    • 5.7.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.3. Cardiology
    • 5.7.3.1. Cardiology market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.4. Neurology
    • 5.7.4.1. Neurology market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.5. Infectious Diseases
    • 5.7.5.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.6. Immunology & Inflammation
    • 5.7.6.1. Immunology & Inflammation market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.7. Others
    • 5.7.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
• 5.8. Biomarker & Imaging Agent Validation
  • 5.8.1. Biomarker & Imaging Agent Validation market estimates and forecasts 2021 to 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Preclinical Imaging End Use Market Movement Analysis
• 6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Pharma and Biotech Companies
  • 6.4.1. Pharma and biotech companies market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Contract Research Organizations (CROs)
  • 6.5.1. Contract Research Organizations (CROs) market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Academic and Research Institutes
  • 6.6.1. Academic and Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Type, Application, End Use

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement structure
    • 7.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement structure
    • 7.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement structure
    • 7.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement structure
    • 7.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement structure
    • 7.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement structure
    • 7.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement structure
    • 7.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement structure
    • 7.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement structure
    • 7.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement structure
    • 7.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement structure
    • 7.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement structure
    • 7.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement structure
    • 7.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement structure
    • 7.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement structure
    • 7.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement structure
    • 7.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement structure
    • 7.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement structure
    • 7.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement structure
    • 7.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement structure
    • 7.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement structure
    • 7.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement structure
    • 7.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement structure
    • 7.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2025
• 8.4. Company Position Analysis
• 8.5. Company Categorization (Emerging Players, Innovators and Leaders)
• 8.6. Company Profiles
  • 8.6.1. Cubresa Inc.
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Bruker Corporation
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. Revvity (PerkinElmer, Inc)
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. FUJIFILM VisualSonics
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. Mediso Ltd.
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Rigaku (MILabs B.V.)
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. MR Solutions
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. Aspect Imaging
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. TriFoil Imaging
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. Siemens Healthineers
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America preclinical imaging market, By country, 2021 - 2033 (USD Million)
• Table 3 North America preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 4 North America preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 5 North America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 6 U.S. preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 7 U.S. preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 8 U.S. preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 9 Canada preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 10 Canada preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 11 Canada preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 12 Mexico preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 13 Mexico preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 14 Mexico preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 15 Europe preclinical imaging market, By country, 2021 - 2033 (USD Million)
• Table 16 Europe preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 17 Europe preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 18 Europe preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 19 UK preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 20 UK preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 21 UK preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 22 Germany preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 23 Germany preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 24 Germany preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 25 France preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 26 France preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 27 France preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 28 Italy preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 29 Italy preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 30 Italy preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 31 Denmark preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 32 Denmark preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 33 Denmark preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 34 Sweden preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 35 Sweden preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 36 Sweden preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 37 Norway preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 38 Norway preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 39 Norway preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 40 Asia Pacific preclinical imaging market, By country, 2021 - 2033 (USD Million)
• Table 41 Asia Pacific preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 42 Asia Pacific preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 43 Asia Pacific preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 44 Japan preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 45 Japan preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 46 Japan preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 47 China preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 48 China preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 49 China preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 50 India preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 51 India preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 52 India preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 53 Australia preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 54 Australia preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 55 Australia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 56 South Korea preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 57 South Korea preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 58 South Korea preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 59 Thailand preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 60 Thailand preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 61 Thailand preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 62 Latin America preclinical imaging market, By Country, 2021 - 2033 (USD Million)
• Table 63 Latin America preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 64 Latin America preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 65 Latin America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 66 Brazil preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 67 Brazil preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 68 Brazil preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 69 Argentina preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 70 Argentina preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 71 Argentina preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 72 Middle East & Africa preclinical imaging market, By country, 2021 - 2033 (USD Million)
• Table 73 Middle East & Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 74 Middle East & Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 75 Middle East & Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 76 South Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 77 South Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 78 South Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 79 Saudi Arabia preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 80 Saudi Arabia preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 81 Saudi Arabia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 82 UAE preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 83 UAE preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 84 UAE preclinical imaging market, By end use, 2021 - 2033 (USD Million)
• Table 85 Kuwait preclinical imaging market, By type, 2021 - 2033 (USD Million)
• Table 86 Kuwait preclinical imaging market, By application, 2021 - 2033 (USD Million)
• Table 87 Kuwait preclinical imaging market, By end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Preclinical imaging market: Market outlook
• Fig. 14 Preclinical imaging market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Preclinical imaging market driver impact
• Fig. 20 Preclinical imaging restraint impact
• Fig. 21 Preclinical imaging market: type movement analysis
• Fig. 22 Preclinical imaging market: type outlook and key takeaways
• Fig. 23 Modality market estimates and forecast, 2021 - 2033
• Fig. 24 Optical Imaging (BLI & F) market estimates and forecast, 2021 - 2033
• Fig. 25 MRI market estimates and forecast, 2021 - 2033
• Fig. 26 PET market estimates and forecast, 2021 - 2033
• Fig. 27 SPECT market estimates and forecast, 2021 - 2033
• Fig. 28 CT market estimates and forecast, 2021 - 2033
• Fig. 29 Ultrasound Imaging (US) market estimates and forecast, 2021 - 2033
• Fig. 30 Photoacoustic Imaging (PAI) market estimates and forecast, 2021 - 2033
• Fig. 31 Hybrid Imaging Systems market estimates and forecast, 2021 - 2033
• Fig. 32 Bi-Modal market estimates and forecast, 2021 - 2033
• Fig. 33 SPECT-CT market estimates and forecast, 2021 - 2033
• Fig. 34 PET-CT market estimates and forecast, 2021 - 2033
• Fig. 35 SPECT-PET market estimates and forecast, 2021 - 2033
• Fig. 36 PET-MRI market estimates and forecast, 2021 - 2033
• Fig. 37 Optical-CT market estimates and forecast, 2021 - 2033
• Fig. 38 Others market estimates and forecast, 2021 - 2033
• Fig. 39 Tri-Modal market estimates and forecast, 2021 - 2033
• Fig. 40 PET-SPECT-CT market estimates and forecast, 2021 - 2033
• Fig. 41 PET-SPECT-MRI market estimates and forecast, 2021 - 2033
• Fig. 42 PET-CT-Optical market estimates and forecast, 2021 - 2033
• Fig. 43 Others market estimates and forecast, 2021 - 2033
• Fig. 44 Reagents market estimates and forecast, 2021 - 2033
• Fig. 45 Services market estimates and forecast, 2021 - 2033
• Fig. 46 Preclinical imaging market: application movement analysis
• Fig. 47 Preclinical imaging market: application outlook and key takeaways
• Fig. 48 Drug Discovery & Development market estimates and forecast, 2021 - 2033
• Fig. 49 Toxicology & Pharmacokinetics Studies market estimates and forecast, 2021 - 2033
• Fig. 50 Basic & Translational Research market estimates and forecast, 2021 - 2033
• Fig. 51 Disease Mechanism & Pathophysiology Studies market estimates and forecast, 2021 - 2033
• Fig. 52 Oncology market estimates and forecast, 2021 - 2033
• Fig. 53 Cardiology market estimates and forecast, 2021 - 2033
• Fig. 54 Neurology market estimates and forecast, 2021 - 2033
• Fig. 55 Infectious Diseases market estimates and forecast, 2021 - 2033
• Fig. 56 Immunology & Inflammation market estimates and forecast, 2021 - 2033
• Fig. 57 Others market estimates and forecast, 2021 - 2033
• Fig. 58 Biomarker & Imaging Agent Validation market estimates and forecast, 2021 - 2033
• Fig. 59 Others market estimates and forecast, 2021 - 2033
• Fig. 60 Preclinical imaging market: end use movement analysis
• Fig. 61 Preclinical imaging market: end use outlook and key takeaways
• Fig. 62 Pharma and biotech companies market estimates and forecast, 2021 - 2033
• Fig. 63 Contract Research Organizations (CROs) market estimates and forecast, 2021 - 2033
• Fig. 64 Academic and Research Institutes market estimates and forecast, 2021 - 2033
• Fig. 65 Others market estimates and forecast, 2021 - 2033
• Fig. 66 Global Preclinical Imaging Market: regional movement analysis
• Fig. 67 Global Preclinical Imaging Market: regional outlook and key takeaways
• Fig. 68 North America
• Fig. 69 North America market estimates and forecast, 2021 - 2033
• Fig. 70 U.S.
• Fig. 71 U.S. market estimates and forecast, 2021 - 2033
• Fig. 72 Canada
• Fig. 73 Canada market estimates and forecast, 2021 - 2033
• Fig. 74 Mexico
• Fig. 75 Mexico market estimates and forecast, 2021 - 2033
• Fig. 76 Europe
• Fig. 77 Europe. market estimates and forecast, 2021 - 2033
• Fig. 78 UK
• Fig. 79 UK market estimates and forecast, 2021 - 2033
• Fig. 80 Germany
• Fig. 81 Germany market estimates and forecast, 2021 - 2033
• Fig. 82 France
• Fig. 83 France market estimates and forecast, 2021 - 2033
• Fig. 84 Italy
• Fig. 85 Italy market estimates and forecast, 2021 - 2033
• Fig. 86 Spain
• Fig. 87 Spain market estimates and forecast, 2021 - 2033
• Fig. 88 Denmark
• Fig. 89 Denmark market estimates and forecast, 2021 - 2033
• Fig. 90 Sweden
• Fig. 91 Sweden market estimates and forecast, 2021 - 2033
• Fig. 92 Norway
• Fig. 93 Norway market estimates and forecast, 2021 - 2033
• Fig. 94 Asia Pacific
• Fig. 95 Asia Pacific market estimates and forecast, 2021 - 2033
• Fig. 96 Japan
• Fig. 97 Japan market estimates and forecast, 2021 - 2033
• Fig. 98 China
• Fig. 99 China market estimates and forecast, 2021 - 2033
• Fig. 100 India
• Fig. 101 India market estimates and forecast, 2021 - 2033
• Fig. 102 South Korea
• Fig. 103 South Korea market estimates and forecast, 2021 - 2033
• Fig. 104 Thailand
• Fig. 105 Thailand market estimates and forecast, 2021 - 2033
• Fig. 106 Australia
• Fig. 107 Australia market estimates and forecast, 2021 - 2033
• Fig. 108 Latin America
• Fig. 109 Latin America market estimates and forecast, 2021 - 2033
• Fig. 110 Brazil
• Fig. 111 Brazil market estimates and forecast, 2021 - 2033
• Fig. 112 Argentina
• Fig. 113 Argentina market estimates and forecast, 2021 - 2033
• Fig. 114 Middle East and Africa
• Fig. 115 Middle East and Africa. market estimates and forecast, 2021 - 2033
• Fig. 116 Saudi Arabia
• Fig. 117 Saudi Arabia market estimates and forecast, 2021 - 2033
• Fig. 118 South Africa
• Fig. 119 South Africa market estimates and forecast, 2021 - 2033
• Fig. 120 UAE
• Fig. 121 UAE market estimates and forecast, 2021 - 2033
• Fig. 122 Kuwait
• Fig. 123 Kuwait market estimates and forecast, 2021 - 2033
• Fig. 124 Participant categorization- Preclinical imaging market
• Fig. 125 Market share of key market players- Preclinical imaging market